Hybridoma Selection

Our Smart Selection Approach

Hybridomas are immortal somatic cell hybrids that secrete antibodies. Hybridoma generation is a critical step in making monoclonal antibodies. A major barrier to monoclonal antibody discovery is hybridoma selection. Hundreds to thousands of hybridoma cells have to be manually screened in the hope of identifying antibody-secreting clones.

BiCell Scientific Inc has developed a “smart” selection approach to identify antibody-secreting hybridoma cells and streamlined the process for monoclonal antibody production.

Flow chart of “smart” hybridoma selection

Step 1:

Mouse is immunized with antigen

Step 2:

Splenocytes from immunized mouse are isolated

Step 3:

Splenocytes are fused with myeloma cells (our electrofusion protocol can generate 1 hybridoma clone out of 104 splenocytes)

Step 4:

Hybridoma cells are treated by a proprietary crosslinking protocol to immobilize antibodies on the cell surface

Step 5:

Fluorophore labeled antigen molecules allow identifying positive hybridoma cells by direct binding to the hybridoma cell surface

Step 6:

Fluorescence based cell sorting

Step 7:

Dilution cloning and clonal selection


Electrofusion efficiently fuses myeloma cells with splenocytes. Circle indicates fusion event. Myeloma cells: large nuclei; splenocytes: small nuclei.


Antigen labeling of hybridoma cells. Hybridoma cells are transiently crosslinked to immobilize antibodies on the cell surface. FITC-labeled antigen binds to and decorates the hybridoma cell that secretes the correct antibody.

Contact us for questions or custom requests!